Of the many factors that raise the odds of developing dementia, some cannot be changed, such as age and genetics. But a landmark review of the evidence identified hearing loss during the middle years of life as the single largest risk factor that can actually be altered. That conclusion, from an international panel convened by The Lancet, reframed a problem often dismissed as an ordinary nuisance of aging into one of the more promising targets for protecting the brain.
The distinction that matters is modifiability. A risk factor that responds to treatment offers a route to lowering dementia rates across a population, and hearing loss is both common and, in many cases, correctable with devices and care. That combination is why researchers have pushed for it to be taken far more seriously in midlife, well before memory problems appear.
The Lancet Commission ranked hearing loss the top midlife risk
In 2020, the Lancet Commission on dementia prevention, intervention and care set out a list of factors that, if addressed, could delay or prevent a meaningful share of cases. The panel calculated that roughly 40 percent of dementias could theoretically be prevented or delayed by tackling twelve modifiable risks across the lifespan. Among them, hearing loss in midlife stood out as the largest single contributor.
The commission expressed that contribution as a population attributable fraction of about 8 percent, meaning that eliminating midlife hearing loss might, in principle, prevent close to that proportion of dementia cases. No other single modifiable factor on the list carried a larger share. The figure is a population-level estimate rather than a personal prediction, but it placed hearing squarely at the front of the prevention agenda.
An updated tally kept hearing loss near the top
When the commission revisited the evidence in 2024, it expanded the roster of modifiable factors to fourteen and raised the overall share of potentially preventable dementia. The 2024 update concluded that addressing the full set of risks could prevent or delay close to 45 percent of cases, adding untreated vision loss and high cholesterol to the earlier list.
Even with a longer list of competitors, hearing loss remained among the most influential midlife risks in the updated accounting. Its persistence near the top across two rounds of review, several years apart, gave the finding durability, signaling that it was not an artifact of one analysis but a consistent read of the accumulating evidence.
Several theories explain the hearing-dementia link
Why poor hearing would harm the brain is not settled, and researchers describe several overlapping possibilities. One holds that straining to decode muffled sound diverts mental resources away from memory and thinking, imposing a chronic cognitive load. Another points to the way reduced input to the auditory system may contribute over time to shrinkage in brain regions that process sound and language.
A third explanation runs through social life. Difficulty following conversation can push people to withdraw, and the resulting isolation and reduced mental stimulation are themselves recognized risks for cognitive decline. These pathways are not mutually exclusive, and the true relationship may involve a mix of them, which complicates any claim that hearing loss causes dementia in a simple, direct line.
A randomized trial tested whether treating hearing helps
The strongest way to probe whether treatment matters is a randomized trial, and one such study, known as ACHIEVE, followed nearly a thousand older adults with untreated hearing loss for three years. Across the whole group, providing hearing aids and support did not significantly slow cognitive decline compared with a health-education control.
A prespecified analysis, however, told a more encouraging story for those at higher risk. Among participants who were older and already more vulnerable to decline, the hearing intervention was associated with a 48 percent reduction in the loss of thinking and memory over the three years. That split result suggests treating hearing may protect the brain most in the people most likely to be slipping, while stopping short of proving benefit for everyone.
Why the word preventable comes with caveats
The prevention estimates rest on assumptions worth keeping in view. A population attributable fraction presumes that a risk factor is genuinely causal and that removing it would erase its share of cases, yet much of the underlying evidence is observational and cannot fully rule out that hearing loss and dementia share common roots. The 8 percent figure is best read as a well-founded projection, not a promise.
What is not in dispute is that hearing loss is treatable and that its treatment carries little downside. Even if the precise share of preventable dementia is uncertain, addressing hearing in midlife improves communication and quality of life on its own terms, while offering a plausible and low-risk chance of protecting the aging brain. That balance is what keeps it near the center of dementia-prevention advice.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
